EYEN Eyenovia Corp Revenue Growth QoQ

Public company logo of Eyenovia, Inc. (EYEN)

Eyenovia, Inc. (EYEN) transformed ophthalmology by introducing the precision Optejet spray to combat myopia. However, failures in the drug's final tests depleted capital, necessitating an urgent search for investors. Patents and strict FDA oversight create a high barrier to entry, which is confirmed by the GURU.Markets system summary chart: the quarterly revenue change indicator currently has the status 194.60.

EYEN eyenovia.com Quarterly Revenue Growth Rate (07/04/2022 - 07/03/2025)

Metric breakdowns and analytics for Eyenovia Corp (EYEN)

- stock price and consensus target price:
- market capitalization data:
Analysis of all company metrics:Eyenovia Corp - EYEN
Manufactured products of Eyenovia Inc.

This metric reflects the dynamics of cash flow from operating activities by calculating the percentage deviation of current revenue from the previous quarter to assess business scaling. By analyzing the quarterly revenue growth trend, an investor can gauge the effectiveness of Eyenovia, Inc. (EYEN) technology commercialization amid strict FDA oversight and high R&D costs, which confirms the overcoming of patent barriers.